The long-term safety and efficacy of 0.01% halobetasol propionate and 0.045% tazarotene (HP/TAZ) lotion in patients with psoriasis previously treated with topicals is evaluated.
The 12-week studies sought to determine safety and efficacy of fixed-dose clindamycin 1.2%, benzoyl peroxide 3.1%, and adapalene 0.15% gel for the treatment of acne.
Patients with Steven Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) overlap treated with etanercept monotherapy not alternative therapies were assessed.
Patients with hidradenitis suppurativa (HS) who had elevated circulating blood inflammatory markers were associated with poorer clinical outcomes, according to study results presented at the 2022 Annual Meeting of the American Academy of Dermatology (AAD), held from March 25 to 29, 2022. The chronic inflammatory condition HS is characterized by recurrent tunnels, nodules, and scarring…
To evaluate the safety and efficacy of imsidolimab in generalized pustular psoriasis (GPP), the design of a phase 3, international, multicenter, randomized, double-blind, placebo-controlled trial called Gemini-1 (ANB019-301) is proposed.
Glaucoma, dry eye, cataracts, and diabetic macular edema are all more likely to occur in individuals with diabetes who have rosacea than in those without rosacea, according to a presentation at the AAD.
As social media becomes a more and more popular platform on which to post content on various skin disorders, researchers sought to evaluate medical and patient-oriented posts for skin disorders on Instagram, Twitter, and TikTok.
Researchers aimed to assess whether the risk of developing maskne is higher among health care workers with a history of acne and to evaluate potential risk factors for the development of maskne.
Researchers sought to determine the long-term efficacy of baricitinib combined therapy with topical corticosteroids in patients with moderate to severe atopic dermatitis.
National Medicare claims data were used to compare risk-adjusted mortality, readmissions, length of stay, and costs at Society of Dermatology Hospitalists (SODH) hospitals compared with nonmember hospitals.
The team at Dermatology Advisor will be reporting on the latest news and research conducted by leading experts in dermatology and presented at the 2022 American Academy of Dermatology Annual Meeting, being held live from March 25 through March 29 in Boston, Massachusetts.